First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.81 EUR -1.75%
Updated: Apr 23, 2024

BRAIN Biotech AG
Net Income (Common)

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Net Income (Common) Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Net Income (Common)
€-8.4m
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Net Income (Common)
€313.6m
CAGR 3-Years
18%
CAGR 5-Years
5%
CAGR 10-Years
61%
Evonik Industries AG
XETRA:EVK
Net Income (Common)
€-465m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covestro AG
XETRA:1COV
Net Income (Common)
€-198m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Net Income (Common)
€34.6m
CAGR 3-Years
21%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Net Income (Common)
€340.5m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%

See Also

What is BRAIN Biotech AG's Net Income (Common)?
Net Income (Common)
-8.4m EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Net Income (Common) amounts to -8.4m EUR.

What is BRAIN Biotech AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%

Over the last year, the Net Income (Common) growth was -24%. The average annual Net Income (Common) growth rates for BRAIN Biotech AG have been 8% over the past three years , 2% over the past five years .